home / stock / igms / igms message board
Subject | By | Source | When |
---|---|---|---|
bears are running | crudeoil24 | investorshub | 06/21/2023 6:16:13 AM |
short squeeze signal | TheFinalCD | investorshub | 05/29/2023 1:56:07 PM |
AviseAnalytics: 5 THINGS YOU MUST KNOW ABOUT IGM BIOSCIENCES! $IGMS IGM Biosciences, Inc. (NASDAQ: | AviseAnalytics | investorshangout | 04/01/2022 1:02:41 PM |
Truist Reiterates Buy Rating, $80 Price Target. | crudeoil24 | investorshub | 03/29/2022 5:20:52 PM |
Let's see if $IGMS gets FDA phase | crudeoil24 | investorshub | 03/29/2022 4:57:42 PM |
14M float! | crudeoil24 | investorshub | 03/29/2022 4:54:58 PM |
Tons of cash going forward > IGM Biosciences, | crudeoil24 | investorshub | 03/29/2022 4:40:20 PM |
https://ih.advfn.com/stock-market/NASDAQ/igm-biosciences-IGMS/stock-news/87682546/igm-announces-prop | TheFinalCD | investorshub | 03/29/2022 4:05:17 PM |
News, Short Squeeze, Breakout and More Instantly...
IGM Biosciences Inc. Company Name:
IGMS Stock Symbol:
NYSE Market:
2024-04-22 09:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MOUNTAIN VIEW, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that the Company’s exclusive worldwide collaboration agreement with Sanofi to create and...
MOUNTAIN VIEW, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Stifel...